Inspira Technologies Oxy B.H.N. Ltd. (IINN)
NASDAQ: IINN · Real-Time Price · USD
0.480
-0.029 (-5.72%)
At close: Apr 28, 2026, 4:00 PM EDT
0.472
-0.008 (-1.75%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Company Description
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.
It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements.
The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N.
Ltd. in July 2020. Inspira Technologies Oxy B.H.N.
Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Inspira Technologies Oxy B.H.N. Ltd.
| Country | Israel |
| Founded | 2018 |
| IPO Date | Jul 14, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 37 |
| CEO | Dagi Ben-Noon |
Contact Details
Address: 2 Ha-Tidhar St. Ra'anana, 4366504 Israel | |
| Phone | 972 4 623 0333 |
| Website | inspira-technologies.com |
Stock Details
| Ticker Symbol | IINN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.51 |
| CIK Code | 0001837493 |
| CUSIP Number | M53637100 |
| ISIN Number | IL0011715781 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dagi Shahar Ben-Noon | Co-Founder, Chief Executive Officer and Director |
| Yafit Tehila | Chief Financial Officer |
| Avi Shabtai | Chief Operating Officer and Vice President of Research and Development |
| Daniella Yeheskely-Hayon M.B.A., Ph.D. | Chief Technology Officer |
| Sivan Ozeri | Administrative Manager |
| Adi Shmueli | Director of Marketing |
| Mike Hershkovitz | Vice President of Global Sales |
| Yoav Rozanovich | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 28, 2026 | 6-K | Report of foreign issuer |
| Apr 16, 2026 | 6-K | Report of foreign issuer |
| Apr 16, 2026 | 6-K | Report of foreign issuer |
| Apr 15, 2026 | 6-K | Report of foreign issuer |
| Apr 14, 2026 | 6-K | Report of foreign issuer |
| Apr 13, 2026 | 6-K | Report of foreign issuer |
| Apr 6, 2026 | 6-K | Report of foreign issuer |
| Apr 6, 2026 | 6-K | Report of foreign issuer |
| Mar 31, 2026 | 6-K | Report of foreign issuer |
| Mar 26, 2026 | 6-K | Report of foreign issuer |